JP2021508313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508313A5 JP2021508313A5 JP2020518541A JP2020518541A JP2021508313A5 JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5 JP 2020518541 A JP2020518541 A JP 2020518541A JP 2020518541 A JP2020518541 A JP 2020518541A JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- microbial flora
- sequence variant
- tumor
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2017/075683 | 2017-10-09 | ||
| PCT/EP2017/075683 WO2018065628A2 (en) | 2016-10-07 | 2017-10-09 | Microbiota sequence variants of tumor-related antigenic epitopes |
| EP17195520 | 2017-10-09 | ||
| EP17195520.6 | 2017-10-09 | ||
| EP18305442 | 2018-04-11 | ||
| EP18305442.8 | 2018-04-11 | ||
| PCT/EP2018/077515 WO2019072871A2 (en) | 2017-10-09 | 2018-10-09 | MICROBIOTIC SEQUENCE VARIANTS OF ANTIGENIC EPITOPES ASSOCIATED WITH A TUMOR |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508313A JP2021508313A (ja) | 2021-03-04 |
| JP2021508313A5 true JP2021508313A5 (https=) | 2021-11-18 |
| JP7232825B2 JP7232825B2 (ja) | 2023-03-03 |
Family
ID=66100441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518541A Active JP7232825B2 (ja) | 2017-10-09 | 2018-10-09 | 腫瘍関連抗原エピトープの微生物叢（ｍｉｃｒｏｂｉｏｔａ）配列変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200256877A1 (https=) |
| EP (1) | EP3694541A2 (https=) |
| JP (1) | JP7232825B2 (https=) |
| KR (1) | KR102823291B1 (https=) |
| CN (1) | CN111201032B (https=) |
| AU (1) | AU2018348432B2 (https=) |
| CA (1) | CA3075363A1 (https=) |
| IL (1) | IL273648B2 (https=) |
| WO (1) | WO2019072871A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102622188B1 (ko) | 2016-10-07 | 2024-01-05 | 엔터롬 에스.에이. | 암 치료를 위한 면역원성 화합물 |
| WO2018065628A2 (en) | 2016-10-07 | 2018-04-12 | Enterome | Microbiota sequence variants of tumor-related antigenic epitopes |
| US11478538B2 (en) | 2016-10-07 | 2022-10-25 | Enterome S.A. | Immunogenic compounds for cancer therapy |
| CN112118863B (zh) | 2018-04-11 | 2025-05-30 | 恩特罗姆公司 | 用于预防和治疗癌症的抗原肽 |
| EP3773673A2 (en) * | 2018-04-11 | 2021-02-17 | Enterome S.A. | Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation |
| WO2021074389A1 (en) * | 2019-10-16 | 2021-04-22 | Enterome S.A. | Immunogenic compounds for treatment of adrenal cancer |
| ES2971929T3 (es) * | 2019-11-15 | 2024-06-10 | Enterome S A | Péptidos antigénicos para la prevención y el tratamiento de la neoplasia maligna de linfocitos B |
| CN112481299A (zh) * | 2020-11-20 | 2021-03-12 | 郑州大学 | 用于调节PD-1/PD-L1通路的RNAi表达质粒 |
| WO2023244997A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for inducing anticancer immunity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20131167T1 (hr) | 2007-06-18 | 2014-01-03 | Merck Sharp & Dohme B.V. | Antitijela za humani receptor programirane smrti pd-1 |
| EP2189471B1 (en) * | 2007-08-20 | 2017-10-04 | Oncotherapy Science, Inc. | Foxm1 peptide and medicinal agent comprising the same |
| SI2119726T2 (en) | 2008-05-14 | 2018-03-30 | Immatics Biotechnologies Gmbh | New and powerful Class II MHC peptides derived from survivin and neurocane |
| AU2009333580B2 (en) | 2008-12-09 | 2016-07-07 | Genentech, Inc. | Anti-PD-L1 antibodies and their use to enhance T-cell function |
| NZ628923A (en) | 2009-11-24 | 2016-02-26 | Medimmune Ltd | Targeted binding agents against b7-h1 |
| WO2011140284A2 (en) * | 2010-05-04 | 2011-11-10 | Fred Hutchinson Cancer Research Center | Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses |
| EP2608799B1 (en) * | 2010-08-24 | 2018-12-12 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| EP2639299A1 (en) | 2012-03-16 | 2013-09-18 | Invectys | Universal cancer peptides derived from telomerase |
| AU2014239883B2 (en) * | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
-
2018
- 2018-10-09 WO PCT/EP2018/077515 patent/WO2019072871A2/en not_active Ceased
- 2018-10-09 AU AU2018348432A patent/AU2018348432B2/en active Active
- 2018-10-09 JP JP2020518541A patent/JP7232825B2/ja active Active
- 2018-10-09 CA CA3075363A patent/CA3075363A1/en active Pending
- 2018-10-09 US US16/753,657 patent/US20200256877A1/en not_active Abandoned
- 2018-10-09 KR KR1020207013061A patent/KR102823291B1/ko active Active
- 2018-10-09 IL IL273648A patent/IL273648B2/en unknown
- 2018-10-09 EP EP18782459.4A patent/EP3694541A2/en active Pending
- 2018-10-09 CN CN201880065726.XA patent/CN111201032B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508313A5 (https=) | ||
| IL273648B1 (en) | Microbiota sequence variants of tumor-related antigenic epitopes | |
| US5698396A (en) | Method for identifying auto-immunoreactive substances from a subject | |
| Sioud et al. | Profiling the immune response in patients with breast cancer by phage‐displayed cDNA libraries | |
| JP2006515749A5 (https=) | ||
| EP0807178B1 (fr) | Proteines de mycobacteries, microorganismes les produisant et leurs utilisations vaccinales et pour la detection de la tuberculose | |
| WO1986004093A1 (en) | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases | |
| JP2020500015A5 (https=) | ||
| JP2011523550A5 (https=) | ||
| JP2019507341A5 (https=) | ||
| US20240302377A1 (en) | Methods of identifying novel proteins and antigens in cancer cells | |
| JP2004154141A (ja) | リステリア検出のための方法および試薬 | |
| CA2110389A1 (fr) | Proteines de mycobacterium et applications | |
| DK200601181A (da) | Fiskevaccine | |
| JP2024023268A5 (https=) | ||
| EP1238102B1 (en) | Microbial polynucleotides expressed during infection of a host | |
| JP2004512529A (ja) | 細胞内エピトープの生体内同定方法 | |
| CN107759692A (zh) | 一种抗ca125的纳米抗体 | |
| McMillan et al. | Identification and assessment of new vaccine candidates for group A streptococcal infections | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| JP2020505056A5 (https=) | ||
| Vera-Bravo et al. | Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines | |
| CN109669043B (zh) | 一种mhc i结合多肽基序的鉴定方法 | |
| CN120535638B (zh) | 一种抗泛赖氨酰氧化酶家族纳米抗体或抗原结合片段与应用 | |
| JP4087326B2 (ja) | クロマチン免疫沈降用レジンおよびこれを利用したクロマチン免疫沈降法 |